The Industry’s Leading Forum Focused on Securing & Scaling Radiopharmaceutical Manufacturing & Supply
What We Explored In 2025:
- Uncover emerging solutions to radioisotope supply challenge by addressing logistics bottlenecks, comparing centralized versus local production models, managing the impact of transport delays on dose integrity, and optimizing tracking and planning for clinical demand.
- Advance your radiopharmaceutical manufacturing strategy by exploring scalable production strategies, efficient Phase 3 to commercial transitions, and flexible designs that accommodate isotope variability and short half-lives.
- Gain regulatory clarity to accelerate your clinical trials with practical guidance on agency-specific DMF expectations, equipment standards, and balancing transparency with IP protection – designed to strengthen alignment between pharma and supplier partnerships.
- Ensure consistent quality across radiopharmaceutical operations by managing supplier and CDMO oversight, implementing strong quality management systems throughout clinical and commercial stages, and leveraging quality metrics to guide risk management and decision-making.
- Strengthen your scientific and commercial partnerships by connecting with the leaders driving the field forward – understand what’s needed in 2025 to build effective collaborations that support clinical and commercial success.
Your Peers United To:
Demystify global regulatory expectations
Streamline submissions, safeguard IP, align on isotope standards, and fast-track radiotherapeutic development with AstraZeneca
Master radiotherapeutic manufacturing
Design robust, future-proof processes that adapt to demand and isotope variability with Clarity Pharmaceuticals and Novartis to master scalable radiotherapeutic manufacturing
Revolutionize radiopharmaceutical automation
Use AI-driven analytics to enhance batch consistency and streamline quality oversight with Ratio Therapeutics
Transform patient delivery
Integrate theranostics centers in manufacturing to ensure dose utilization, accelerate access, and expand regional reach with United Theranostics
What Your Peers Have to Say
The conference attracts real subject matter experts and features valuable exchanges of information. I always learn something and make new contacts.
Brookline Capital Markets
It was very well run. Additionally, it was a good collection of individuals focused on a key topic.
Cellectar Biosciences
I like the variety of topics for this industry. This year it was great to hear about safety and automation.
Nucleas Radiopharma
It was a radiopharma meeting that focused on supply chain. Few conferences like this in our industry.
POINT Biopharma
Explore the Full 2025 Event Guide
- Get a full overview of the agenda, speakers, and sessions in one place
- Preview featured case studies that we’ll be shining a light on
- Discover exclusive content such as keynote highlights, attendee benefits and more
- Share easily with colleagues and decision-makers to mobilize interest
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.